Developing Anticancer Drugs in Orphan Molecular Entities — A Paradigm under Construction

Genomic characterization of cancers has shown that some oncogenic alterations occur at very low frequency and are shared across tumor types. For example, NTRK translocations mediate malignant transformation and are observed in less than 1% of cancers and in more than 20 cancer types. The genes…

http://ift.tt/2opd0BH